Global Diagnostic Radiopharmaceuticals Market Growth 2020-2025
According to this study, over the next five years the Diagnostic Radiopharmaceuticals market will register a 7.2%% CAGR in terms of revenue, the global market size will reach $ 4995.7 million by 2025, from $ 3788.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diagnostic Radiopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Diagnostic Radiopharmaceuticals, covering the supply chain analysis, impact assessment to the Diagnostic Radiopharmaceuticals market size growth rate in several scenarios, and the measures to be undertaken by Diagnostic Radiopharmaceuticals companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Technetium 99
Fluorine 18
Other
Diagnostic radiopharmaceuticals are mainly divided into technetium 99, fluorine 18 and others. Among them, technetium 99 accounted for the main part, accounting for about 47.56% of the total market in 2019.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
Diagnostic radiopharmaceutical applications are mainly for oncology, cardiology and others. Among them, oncology accounts for the main part, accounting for about 45.8% of the total market in 2019.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Cardinal Health
Lantheus
GE Healthcare
Jubilant Pharma
Bracco Imaging
Curium Pharma
China Isotope & Radiation
Advanced Accelerator Applications
Dongcheng Pharmaceutical Group
SIEMENS
Eli Lilly
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diagnostic Radiopharmaceuticals consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Diagnostic Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Diagnostic Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diagnostic Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diagnostic Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Consumption 2015-2025
2.1.2 Diagnostic Radiopharmaceuticals Consumption CAGR by Region
2.2 Diagnostic Radiopharmaceuticals Segment by Type
2.2.1 Technetium 99
2.2.2 Fluorine 18
2.2.3 Other
2.3 Diagnostic Radiopharmaceuticals Consumption by Type
2.3.1 Global Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
2.3.2 Global Diagnostic Radiopharmaceuticals Revenue and Market Share by Type (2015-2020)
2.3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Type (2015-2020)
2.4 Diagnostic Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Radiopharmaceuticals Consumption by Application
2.5.1 Global Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
2.5.2 Global Diagnostic Radiopharmaceuticals Value and Market Share by Type (2015-2020)
2.5.3 Global Diagnostic Radiopharmaceuticals Sale Price by Type (2015-2020)
3 Global Diagnostic Radiopharmaceuticals by Company
3.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company
3.1.1 Global Diagnostic Radiopharmaceuticals Sales by Company (2018-2020)
3.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2018-2020)
3.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company
3.2.1 Global Diagnostic Radiopharmaceuticals Revenue by Company (2018-2020)
3.2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2018-2020)
3.3 Global Diagnostic Radiopharmaceuticals Sale Price by Company
3.4 Global Diagnostic Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Diagnostic Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Diagnostic Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Diagnostic Radiopharmaceuticals by Regions
4.1 Diagnostic Radiopharmaceuticals by Regions
4.2 Americas Diagnostic Radiopharmaceuticals Consumption Growth
4.3 APAC Diagnostic Radiopharmaceuticals Consumption Growth
4.4 Europe Diagnostic Radiopharmaceuticals Consumption Growth
4.5 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Growth
5 Americas
5.1 Americas Diagnostic Radiopharmaceuticals Consumption by Countries
5.1.1 Americas Diagnostic Radiopharmaceuticals Consumption by Countries (2015-2020)
5.1.2 Americas Diagnostic Radiopharmaceuticals Value by Countries (2015-2020)
5.2 Americas Diagnostic Radiopharmaceuticals Consumption by Type
5.3 Americas Diagnostic Radiopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Diagnostic Radiopharmaceuticals Consumption by Regions
6.1.1 APAC Diagnostic Radiopharmaceuticals Consumption by Regions (2015-2020)
6.1.2 APAC Diagnostic Radiopharmaceuticals Value by Regions (2015-2020)
6.2 APAC Diagnostic Radiopharmaceuticals Consumption by Type
6.3 APAC Diagnostic Radiopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Diagnostic Radiopharmaceuticals by Countries
7.1.1 Europe Diagnostic Radiopharmaceuticals Consumption by Countries (2015-2020)
7.1.2 Europe Diagnostic Radiopharmaceuticals Value by Countries (2015-2020)
7.2 Europe Diagnostic Radiopharmaceuticals Consumption by Type
7.3 Europe Diagnostic Radiopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Radiopharmaceuticals by Countries
8.1.1 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Diagnostic Radiopharmaceuticals Value by Countries (2015-2020)
8.2 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Type
8.3 Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diagnostic Radiopharmaceuticals Distributors
10.3 Diagnostic Radiopharmaceuticals Customer
11 Global Diagnostic Radiopharmaceuticals Market Forecast
11.1 Global Diagnostic Radiopharmaceuticals Consumption Forecast (2021-2025)
11.2 Global Diagnostic Radiopharmaceuticals Forecast by Regions
11.2.1 Global Diagnostic Radiopharmaceuticals Forecast by Regions (2021-2025)
11.2.2 Global Diagnostic Radiopharmaceuticals Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Diagnostic Radiopharmaceuticals Forecast by Type
11.8 Global Diagnostic Radiopharmaceuticals Forecast by Application
12 Key Players Analysis
12.1 Cardinal Health
12.1.1 Company Information
12.1.2 Diagnostic Radiopharmaceuticals Product Offered
12.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Cardinal Health Latest Developments
12.2 Lantheus
12.2.1 Company Information
12.2.2 Diagnostic Radiopharmaceuticals Product Offered
12.2.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Lantheus Latest Developments
12.3 GE Healthcare
12.3.1 Company Information
12.3.2 Diagnostic Radiopharmaceuticals Product Offered
12.3.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 GE Healthcare Latest Developments
12.4 Jubilant Pharma
12.4.1 Company Information
12.4.2 Diagnostic Radiopharmaceuticals Product Offered
12.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Jubilant Pharma Latest Developments
12.5 Bracco Imaging
12.5.1 Company Information
12.5.2 Diagnostic Radiopharmaceuticals Product Offered
12.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bracco Imaging Latest Developments
12.6 Curium Pharma
12.6.1 Company Information
12.6.2 Diagnostic Radiopharmaceuticals Product Offered
12.6.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Curium Pharma Latest Developments
12.7 China Isotope & Radiation
12.7.1 Company Information
12.7.2 Diagnostic Radiopharmaceuticals Product Offered
12.7.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 China Isotope & Radiation Latest Developments
12.8 Advanced Accelerator Applications
12.8.1 Company Information
12.8.2 Diagnostic Radiopharmaceuticals Product Offered
12.8.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Advanced Accelerator Applications Latest Developments
12.9 Dongcheng Pharmaceutical Group
12.9.1 Company Information
12.9.2 Diagnostic Radiopharmaceuticals Product Offered
12.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Dongcheng Pharmaceutical Group Latest Developments
12.10 SIEMENS
12.10.1 Company Information
12.10.2 Diagnostic Radiopharmaceuticals Product Offered
12.10.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 SIEMENS Latest Developments
12.11 Eli Lilly
12.11.1 Company Information
12.11.2 Diagnostic Radiopharmaceuticals Product Offered
12.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Eli Lilly Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Diagnostic Radiopharmaceuticals Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Technetium 99
Table 5. Major Players of Fluorine 18
Table 6. Major Players of Other
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 9. Global Diagnostic Radiopharmaceuticals Revenue by Type (2015-2020) ($ million)
Table 10. Global Diagnostic Radiopharmaceuticals Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Diagnostic Radiopharmaceuticals Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Diagnostic Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 14. Global Diagnostic Radiopharmaceuticals Value by Application (2015-2020)
Table 15. Global Diagnostic Radiopharmaceuticals Value Market Share by Application (2015-2020)
Table 16. Global Diagnostic Radiopharmaceuticals Sale Price by Application (2015-2020)
Table 17. Global Diagnostic Radiopharmaceuticals Sales by Company (2017-2019) (K Units)
Table 18. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company (2017-2019)
Table 19. Global Diagnostic Radiopharmaceuticals Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company (2017-2019)
Table 21. Global Diagnostic Radiopharmaceuticals Sale Price by Company (2017-2019)
Table 22. Global Diagnostic Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Diagnostic Radiopharmaceuticals Products Offered
Table 24. Diagnostic Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Diagnostic Radiopharmaceuticals Consumption by Regions 2015-2020 (K Units)
Table 26. Global Diagnostic Radiopharmaceuticals Consumption Market Share by Regions 2015-2020
Table 27. Global Diagnostic Radiopharmaceuticals Value by Regions 2015-2020 ($ Millions)
Table 28. Global Diagnostic Radiopharmaceuticals Value Market Share by Regions 2015-2020
Table 29. Americas Diagnostic Radiopharmaceuticals Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Diagnostic Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 31. Americas Diagnostic Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Diagnostic Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 33. Americas Diagnostic Radiopharmaceuticals Consumption by Type (2015-2020) (K Units)
Table 34. Americas Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 35. Americas Diagnostic Radiopharmaceuticals Consumption by Application (2015-2020) (K Units)
Table 36. Americas Diagnostic Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 37. APAC Diagnostic Radiopharmaceuticals Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Diagnostic Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 39. APAC Diagnostic Radiopharmaceuticals Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Diagnostic Radiopharmaceuticals Value Market Share by Regions (2015-2020)
Table 41. APAC Diagnostic Radiopharmaceuticals Consumption by Type (2015-2020) (K Units)
Table 42. APAC Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 43. APAC Diagnostic Radiopharmaceuticals Consumption by Application (2015-2020) (K Units)
Table 44. APAC Diagnostic Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 45. Europe Diagnostic Radiopharmaceuticals Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Diagnostic Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 47. Europe Diagnostic Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Diagnostic Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 49. Europe Diagnostic Radiopharmaceuticals Consumption by Type (2015-2020) (K Units)
Table 50. Europe Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 51. Europe Diagnostic Radiopharmaceuticals Consumption by Application (2015-2020) (K Units)
Table 52. Europe Diagnostic Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Diagnostic Radiopharmaceuticals Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Diagnostic Radiopharmaceuticals Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Table 61. Diagnostic Radiopharmaceuticals Distributors List
Table 62. Diagnostic Radiopharmaceuticals Customer List
Table 63. Global Diagnostic Radiopharmaceuticals Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Diagnostic Radiopharmaceuticals Consumption Market Forecast by Regions
Table 65. Global Diagnostic Radiopharmaceuticals Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Diagnostic Radiopharmaceuticals Value Market Share Forecast by Regions
Table 67. Global Diagnostic Radiopharmaceuticals Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Diagnostic Radiopharmaceuticals Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Diagnostic Radiopharmaceuticals Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Diagnostic Radiopharmaceuticals Value Market Share Forecast by Type (2021-2025)
Table 71. Global Diagnostic Radiopharmaceuticals Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Diagnostic Radiopharmaceuticals Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Diagnostic Radiopharmaceuticals Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Diagnostic Radiopharmaceuticals Value Market Share Forecast by Application (2021-2025)
Table 75. Cardinal Health Product Offered
Table 76. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. Cardinal Health Main Business
Table 78. Cardinal Health Latest Developments
Table 79. Cardinal Health Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 80. Lantheus Product Offered
Table 81. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Lantheus Main Business
Table 83. Lantheus Latest Developments
Table 84. Lantheus Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 85. GE Healthcare Product Offered
Table 86. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. GE Healthcare Main Business
Table 88. GE Healthcare Latest Developments
Table 89. GE Healthcare Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 90. Jubilant Pharma Product Offered
Table 91. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. Jubilant Pharma Main Business
Table 93. Jubilant Pharma Latest Developments
Table 94. Jubilant Pharma Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 95. Bracco Imaging Product Offered
Table 96. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 97. Bracco Imaging Main Business
Table 98. Bracco Imaging Latest Developments
Table 99. Bracco Imaging Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 100. Curium Pharma Product Offered
Table 101. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 102. Curium Pharma Main Business
Table 103. Curium Pharma Latest Developments
Table 104. Curium Pharma Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 105. China Isotope & Radiation Product Offered
Table 106. China Isotope & Radiation Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 107. China Isotope & Radiation Main Business
Table 108. China Isotope & Radiation Latest Developments
Table 109. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 110. Advanced Accelerator Applications Product Offered
Table 111. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Advanced Accelerator Applications Main Business
Table 113. Advanced Accelerator Applications Latest Developments
Table 114. Advanced Accelerator Applications Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 115. Dongcheng Pharmaceutical Group Product Offered
Table 116. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 117. Dongcheng Pharmaceutical Group Main Business
Table 118. Dongcheng Pharmaceutical Group Latest Developments
Table 119. Dongcheng Pharmaceutical Group Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 120. SIEMENS Product Offered
Table 121. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 122. SIEMENS Main Business
Table 123. SIEMENS Latest Developments
Table 124. SIEMENS Basic Information, Company Total Revenue (in $ million), Diagnostic Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 125. Eli Lilly Product Offered
Table 126. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 127. Eli Lilly Main Business
Table 128. Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Eli Lilly Latest Developments
List of Figures
Figure 1. Picture of Diagnostic Radiopharmaceuticals
Figure 2. Diagnostic Radiopharmaceuticals Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Diagnostic Radiopharmaceuticals Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Diagnostic Radiopharmaceuticals Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Technetium 99
Figure 7. Product Picture of Fluorine 18
Figure 8. Product Picture of Other
Figure 9. Global Diagnostic Radiopharmaceuticals Consumption Market Share by Type (2015-2020)
Figure 10. Global Diagnostic Radiopharmaceuticals Value Market Share by Type (2015-2020)
Figure 11. Diagnostic Radiopharmaceuticals Consumed in Oncology
Figure 12. Global Diagnostic Radiopharmaceuticals Market: Oncology (2015-2020) (K Units)
Figure 13. Global Diagnostic Radiopharmaceuticals Market: Oncology (2015-2020) ($ Millions)
Figure 14. Diagnostic Radiopharmaceuticals Consumed in Cardiology
Figure 15. Global Diagnostic Radiopharmaceuticals Market: Cardiology (2015-2020) (K Units)
Figure 16. Global Diagnostic Radiopharmaceuticals Market: Cardiology (2015-2020) ($ Millions)
Figure 17. Diagnostic Radiopharmaceuticals Consumed in Other
Figure 18. Global Diagnostic Radiopharmaceuticals Market: Other (2015-2020) (K Units)
Figure 19. Global Diagnostic Radiopharmaceuticals Market: Other (2015-2020) ($ Millions)
Figure 20. Global Diagnostic Radiopharmaceuticals Consumption Market Share by Application (2015-2020)
Figure 21. Global Diagnostic Radiopharmaceuticals Value Market Share by Application (2015-2020)
Figure 22. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2017
Figure 23. Global Diagnostic Radiopharmaceuticals Sales Market Share by Company in 2019
Figure 24. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company in 2017
Figure 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Company in 2019
Figure 26. Global Diagnostic Radiopharmaceuticals Sale Price by Company in 2019
Figure 27. Global Diagnostic Radiopharmaceuticals Consumption Market Share by Regions 2015-2020
Figure 28. Global Diagnostic Radiopharmaceuticals Value Market Share by Regions 2015-2020
Figure 29. Americas Diagnostic Radiopharmaceuticals Consumption 2015-2020 (K Units)
Figure 30. Americas Diagnostic Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 31. APAC Diagnostic Radiopharmaceuticals Consumption 2015-2020 (K Units)
Figure 32. APAC Diagnostic Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 33. Europe Diagnostic Radiopharmaceuticals Consumption 2015-2020 (K Units)
Figure 34. Europe Diagnostic Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Diagnostic Radiopharmaceuticals Value 2015-2020 ($ Millions)
Figure 37. Americas Diagnostic Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 38. Americas Diagnostic Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 39. Americas Diagnostic Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 40. Americas Diagnostic Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 41. United States Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 42. United States Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Diagnostic Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 48. APAC Diagnostic Radiopharmaceuticals Value Market Share by Regions in 2019
Figure 49. APAC Diagnostic Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 50. APAC Diagnostic Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 51. China Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 52. China Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 59. India Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 60. India Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Diagnostic Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 64. Europe Diagnostic Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 65. Europe Diagnostic Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 66. Europe Diagnostic Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 67. Germany Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 69. France Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 70. France Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 71. UK Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 72. UK Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Diagnostic Radiopharmaceuticals Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption Market Share by Application in 2019
Figure 81. Egypt Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Diagnostic Radiopharmaceuticals Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Diagnostic Radiopharmaceuticals Value Growth 2015-2020 ($ Millions)
Figure 91. Global Diagnostic Radiopharmaceuticals Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Diagnostic Radiopharmaceuticals Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 94. Americas Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 95. APAC Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 96. APAC Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 97. Europe Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 98. Europe Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 101. United States Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 102. United States Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 103. Canada Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 104. Canada Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 105. Mexico Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 106. Mexico Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 107. Brazil Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 108. Brazil Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 109. China Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 110. China Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 111. Japan Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 112. Japan Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 113. Korea Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 114. Korea Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 117. India Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 118. India Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 119. Australia Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 120. Australia Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 121. Germany Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 122. Germany Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 123. France Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 124. France Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 125. UK Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 126. UK Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 127. Italy Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 128. Italy Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 129. Russia Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 130. Russia Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 131. Spain Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 132. Spain Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 133. Egypt Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 134. Egypt Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 135. South Africa Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 136. South Africa Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 137. Israel Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 138. Israel Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 139. Turkey Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 140. Turkey Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Diagnostic Radiopharmaceuticals Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Diagnostic Radiopharmaceuticals Value 2021-2025 ($ Millions)
Figure 143. Cardinal Health Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 144. Lantheus Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 145. GE Healthcare Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 146. Jubilant Pharma Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 147. Bracco Imaging Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 148. Curium Pharma Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 149. China Isotope & Radiation Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 150. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 151. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 152. SIEMENS Diagnostic Radiopharmaceuticals Market Share (2018-2020)
Figure 153. Eli Lilly Diagnostic Radiopharmaceuticals Market Share (2018-2020)
